Drug Shortage Report for FLULAVAL TETRA

Last updated on 2019-09-17 History
Report ID 94139
Drug Identification Number 02420783
Brand name FLULAVAL TETRA
Common or Proper name Quadrivalent Influenza Vaccine (Split Virion, Inactivated)
Company Name ID BIOMEDICAL CORPORATION OF QUEBEC
Active Ingredient(s) HAEMAGGLUTININ-STRAIN B HAEMAGGLUTININ-STRAIN B HAEMAGGLUTININ-STRAIN A HAEMAGGLUTININ-STRAIN A
Strength(s) 15MCG 15MCG 15MCG 15MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1 vial X 10 doses
ATC code J07BB
ATC description VIRAL VACCINES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-09-12
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2019-09-17
Company comments 2019-2020 dose yield less than planned. Supply prioritized for public programs. Supply unavailable for private market.
Health Canada comments
Company contact information GlaxoSmithKline Customer Service: 1 800 387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2019-09-17 French Compare
v2 2019-09-17 English Compare
v1 2019-09-17 English Compare